Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.11 B MXN
6.42 M MXN
143.68 M
About ATAI Life Sciences N.V.
Sector
Industry
CEO
Srinivas G. Rao
Website
Headquarters
Amstelveen
Founded
2020
ISIN
NL0015000DX5
FIGI
BBG015LH5L77
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Amstelveen, Netherlands.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ATAI/N is 83.76 MXN — it has decreased by −4.66% in the past 24 hours. Watch ATAI Life Sciences N.V. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange ATAI Life Sciences N.V. stocks are traded under the ticker ATAI/N.
We've gathered analysts' opinions on ATAI Life Sciences N.V. future price: according to them, ATAI/N price has a max estimate of 294.28 MXN and a min estimate of 128.75 MXN. Watch ATAI/N chart and read a more detailed ATAI Life Sciences N.V. stock forecast: see what analysts think of ATAI Life Sciences N.V. and suggest that you do with its stocks.
ATAI/N stock is 4.88% volatile and has beta coefficient of 1.17. Track ATAI Life Sciences N.V. stock price on the chart and check out the list of the most volatile stocks — is ATAI Life Sciences N.V. there?
Today ATAI Life Sciences N.V. has the market capitalization of 21.51 B, it has increased by 1.26% over the last week.
Yes, you can track ATAI Life Sciences N.V. financials in yearly and quarterly reports right on TradingView.
ATAI Life Sciences N.V. is going to release the next earnings report on Nov 18, 2025. Keep track of upcoming events with our Earnings Calendar.
ATAI/N earnings for the last quarter are −2.63 MXN per share, whereas the estimation was −2.19 MXN resulting in a −20.00% surprise. The estimated earnings for the next quarter are −2.00 MXN per share. See more details about ATAI Life Sciences N.V. earnings.
ATAI Life Sciences N.V. revenue for the last quarter amounts to 13.49 M MXN, matching the estimated figure, and no changes in revenue are expected for the next quarter.
ATAI/N net income for the last quarter is −520.15 M MXN, while the quarter before that showed −541.50 M MXN of net income which accounts for 3.94% change. Track more ATAI Life Sciences N.V. financial stats to get the full picture.
No, ATAI/N doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 8, 2025, the company has 54 employees. See our rating of the largest employees — is ATAI Life Sciences N.V. on this list?
Like other stocks, ATAI/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ATAI Life Sciences N.V. stock right from TradingView charts — choose your broker and connect to your account.